The Integrated QC Micro Lab and Data Integrity
Lonza to Host Free Webinar on Integrated QC Processes and Data Integrity
Walkersville, MD, USA / Cologne, Germany, 16 October 2015 – Lonza has announced that it will host a free 60-minute webinar on 3 November 2015 titled “The Integrated QC Micro Lab and Data Integrity.” It will provide details about how laboratory professionals can overcome the limits imposed by paper-based QC micro laboratory processes, which can often be expensive and error-prone, as well as time- and labor-intensive. The webinar will also introduce Lonza’s MODA™ Solution, which enables organizations to automate and integrate their quality-control processes for regulated manufacturing and rapidly advance their “green initiatives” by removing all paper from the process.
To help QC professionals learn about how to integrate device and consumables data with lab compliance activities and understand the advantages of managing this information seamlessly with the MODA™ Solution, specialists from Lonza will discuss the following topics during the webinar:
- What are the basics of data integrity and the reasons why the topic is currently a focus
- What are the compliance issues surrounding the storage and analysis of data from laboratory devices and the use of consumables
- How does the MODA™ Solution provide a single repository for managing the data integrity of QC Micro sampling and testing
Interested parties can register to attend the free webinar by selecting their preferred time below:
- Tuesday, 3 November 2015 – 8 a.m. EST (New York) / 1pm GMT (London) / 2pm CET (Berlin)
https://attendee.gotowebinar.com/register/2253293318183664642
- Tuesday, 3 November 2015 – 10 a.m. PST (Los Angeles) / 1pm EST (New York)
https://attendee.gotowebinar.com/register/4111134817102149634
Speaker: Robert Lutskus, Global Product Delivery Manager at Lonza Bioscience Informatics
Those interested in the topic but unable to join the webinar are invited to visit Lonza’s MODATM Solution product page, where they can find more information. Alternatively, all of Lonza’s webinars can be accessed via the company’s online webinar archive at a later date.
To learn more about Lonza’s free QC webinars, please visit www.lonza.com/qcwebinars
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of about CHF 3.64 billion in 2014 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.
Lonza Contact Information
|
Lonza Cologne GmbH |
Lonza Group Ltd |
Lonza Group Ltd |
|
Manager Marketing Communications |
Head Corporate |
Head External |
|
Petra Haberkamm |
Dominik Werner |
Constance Ward |
|
Tel +49 221 991990 |
Tel +41 61 316 8798 |
Tel +41 61 316 8840 |
|
Fax +49 221 99199498 |
Fax +41 61 316 9540 |
Fax +41 61 316 9840 |
Additional Information and Disclaimer
Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.
